Drug Firms Face Cost Squeeze As Beijing Starts Centralized EDL Bidding Process
This article was originally published in PharmAsia News
Executive Summary
Multinational and domestic drug firms in China brace for mounting price pressure as Beijing starts its centralized bidding process for essential drugs.